MITCHELL DEAN J (CIK 1199297) reported 8 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-24). Recent activity: Sell TBPH (91,204 shares), Sell TBPH (6,009 shares), Buy TBPH (6,009 shares), Buy PRAX (1,371 shares), Buy PRAX (1,932 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | Director | Sell | 91,204 | $0 |
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | Director | Sell | 6,009 | $0 |
| 2026-06-16 | Theravance Biopharma, Inc. (TBPH) | Director | Buy | 6,009 | $0 |
| 2026-06-12 | Praxis Precision Medicines, Inc. (PRAX) | Director | Buy | 1,371 | $0 |
| 2025-09-25 | Praxis Precision Medicines, Inc. (PRAX) | Director | Buy | 1,932 | $27,744 |
| 2025-09-25 | Praxis Precision Medicines, Inc. (PRAX) | Director | Buy | 8,566 | $379,046 |
| 2025-09-25 | Praxis Precision Medicines, Inc. (PRAX) | Director | Buy | 1,753 | $77,202 |
| 2025-05-21 | Theravance Biopharma, Inc. (TBPH) | Director | Buy | 10,649 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24